Target
Hexokinase-4
Ligand
BDBM50394681
Substrate
n/a
Meas. Tech.
ChEMBL_858381 (CHEMBL2168596)
EC50
6900±n/a nM
Citation
 Pfefferkorn, JAGuzman-Perez, ALitchfield, JAiello, RTreadway, JLPettersen, JMinich, MLFilipski, KJJones, CSTu, MAspnes, GRisley, HBian, JStevens, BDBourassa, PD'Aquila, TBaker, LBarucci, NRobertson, ASBourbonais, FDerksen, DRMacdougall, MCabrera, OChen, JLapworth, ALLandro, JAZavadoski, WJAtkinson, KHaddish-Berhane, NTan, BYao, LKosa, REVarma, MVFeng, BDuignan, DBEl-Kattan, AMurdande, SLiu, SAmmirati, MKnafels, JDasilva-Jardine, PSweet, LLiras, SRolph, TP Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. J Med Chem 55:1318-33 (2012) [PubMed]  Article 
Target
Name:
Hexokinase-4
Synonyms:
Gck | HXK4_RAT | Hexokinase type IV
Type:
PROTEIN
Mol. Mass.:
52101.81
Organism:
Rattus norvegicus
Description:
ChEMBL_1279785
Residue:
465
Sequence:
MLDDRARMEATKKEKVEQILAEFQLQEEDLKKVMSRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEAGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDLDKGILLNWTKGFKASGAEGNNIVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDRQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRMVDESSANPGQQLYEKIIGGKYMGELVRLVLLKLVDENLLFHGEASEQLRTRGAFETRFVSQVESDSGDRKQIHNILSTLGLRPSVTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPNCEITFIESEEGSGRGAALVSAVACKKACMLAQ
  
Inhibitor
Name:
BDBM50394681
Synonyms:
CHEMBL2165620
Type:
Small organic molecule
Emp. Form.:
C18H19F3N4O3
Mol. Mass.:
396.3637
SMILES:
OC(=O)c1ccc(NC(=O)[C@H](CC2CCCC2)n2cnc(c2)C(F)(F)F)nc1 |r|
Structure:
Search PDB for entries with ligand similarity: